GLP-1 Analog Use Is Associated with Improved Disease Course in Inflammatory Bowel Disease: A Report from the Epi-IIRN

0
18
This study included 3,737 patients with IBD and type 2 diabetes mellitus, (50.4% ulcerative colitis), of whom 633 were treated with GLP-1 analogs.
[Journal of Crohn’s & Colitis]
Abstract